NU(NU)
NU
Q4 2026 EPS Estimate
$0.22
Nov 12, 2026 · Reports after close
Revenue Estimate
$5.89B
FY2026E EPS$0.84
FY2027E EPS$1.11
Analyst Sentiment
Wall St. Consensus
Hold23 analysts·High coverage
62
Score
13 Buy (57%)8 Hold (35%)2 Sell (8%)
Rating Breakdown
Strong Buy
00%
Buy
1357%
Hold
835%
Sell
29%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$13.00
-10.5%
Consensus
$14.95
+2.9%
Bull
$19.00
+30.8%
12-Month Target Range23 analysts
$13.00$14.95$19.00
Current $14.53Consensus
Current Price
$14.53
Upside to Consensus
$0.42
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+21.36%
EPS+31.72%
FY2028
Rev+18.08%
EPS+29.71%
FY2029
Rev-3.38%
EPS+23.28%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $22.33B | $27.10B | $31.99B | $30.91B |
| Low | $22.04B | $25.31B | $27.03B | $28.42B |
| High | $22.51B | $29.74B | $34.72B | $33.33B |
| EBITDA Avg | $7.22B | $8.76B | $10.34B | $9.99B |
| Low | $7.12B | $8.18B | $8.74B | $9.19B |
| High | $7.28B | $9.62B | $11.22B | $10.77B |
| EBIT Avg | $2.30B | $2.79B | $3.30B | $3.19B |
| Low | $2.27B | $2.61B | $2.79B | $2.93B |
| High | $2.32B | $3.07B | $3.58B | $3.44B |
| Net Income Avg | $4.32B | $5.59B | $7.59B | $8.73B |
| Low | $3.59B | $4.37B | $5.92B | $7.81B |
| High | $4.44B | $6.17B | $9.01B | $9.61B |
| EPS Avg | $0.84 | $1.11 | $1.44 | $1.78 |
| Low | $0.73 | $0.89 | $1.21 | $1.59 |
| High | $0.91 | $1.26 | $1.84 | $1.96 |
| Analysts (Rev / EPS) | 6 / 11 | 7 / 11 | 3 / 10 | 1 / 4 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $5.57B | $5.80B | $5.94B | $6.37B | $6.67B | $6.99B | $6.42B | $6.47B |
| Low | $5.51B | $5.55B | $5.79B | $6.21B | $6.51B | $6.81B | $6.27B | $6.31B |
| High | $5.67B | $6.01B | $6.11B | $6.55B | $6.86B | $7.19B | $6.61B | $6.65B |
| EBITDA Avg | $1.80B | $1.88B | $1.92B | $2.06B | $2.16B | $2.26B | $2.08B | $2.09B |
| Low | $1.78B | $1.79B | $1.87B | $2.01B | $2.10B | $2.20B | $2.03B | $2.04B |
| High | $1.83B | $1.94B | $1.97B | $2.12B | $2.22B | $2.32B | $2.14B | $2.15B |
| EBIT Avg | $574M | $598M | $612M | $657M | $688M | $720M | $662M | $667M |
| Low | $568M | $572M | $597M | $641M | $671M | $702M | $646M | $650M |
| High | $584M | $619M | $630M | $676M | $707M | $741M | $681M | $686M |
| Net Income Avg | $1.06B | $1.18B | $1.24B | $1.37B | $1.42B | $1.56B | $1.47B | $1.42B |
| Low | $1.03B | $893M | $1.20B | $1.33B | $1.37B | $1.51B | $1.42B | $1.38B |
| High | $1.11B | $1.39B | $1.29B | $1.42B | $1.47B | $1.61B | $1.53B | $1.48B |
| EPS Avg | $0.22 | $0.24 | $0.25 | $0.28 | $0.29 | $0.32 | $0.30 | $0.29 |
| Low | $0.21 | $0.18 | $0.25 | $0.27 | $0.28 | $0.31 | $0.29 | $0.28 |
| High | $0.23 | $0.28 | $0.26 | $0.29 | $0.30 | $0.33 | $0.31 | $0.30 |
| Analysts (Rev / EPS) | 3 / 6 | 4 / 9 | 2 / 6 | 2 / 3 | 2 / 3 | 2 / 6 | 1 / 8 | 1 / 4 |